Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—June 12, 2026

BySusan Haigney

June 12th 2026

Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO Growth

ByTom Sellig,Zachary Zubulake

June 12th 2026

Transitioning to fully automated assembly lines

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

ByJordan Xu

June 11th 2026

Demand surge and supply critical issues highlight healthcare system overload with scattered medicine pills on wooden surface under warm light | Image Source: ©Enjoy -stock.adobe.com

USP Reports Drug Discontinuations on the Rise

BySusan Haigney

Published: June 9th 2026 | Updated: June 10th 2026

CPHI Americas Panel Making the Case for Product Carbon Footprints

CPHI Americas: The Business Case for Product Carbon Footprints in Pharma

ByDavid Vázquez,Zachary Zubulake

June 8th 2026

Research Tips To Find Packaging Facts Fast

Articles in this issue

Related Content

PharmTech Weekly Roundup—June 12, 2026

Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO Growth

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

USP Reports Drug Discontinuations on the Rise

CPHI Americas: The Business Case for Product Carbon Footprints in Pharma

Trending on Pharmaceutical Technology

PharmTech Weekly Roundup—June 12, 2026

GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication

Manufacturing Intelligence Episode 4: Cleanroom Digital Twins

USP Reports Drug Discontinuations on the Rise

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push